Literature DB >> 8689512

Bladder cancer producing granulocyte colony-stimulating factor: a case report.

K Nishimura1, M Higashino, T Hara, T Oka.   

Abstract

A rare case of bladder cancer producing granulocyte colony-stimulating factor (G-CSF) is reported. A 63-year-old man with a progressive, grade 3 transitional cell bladder carcinoma, showed marked leukocytosis (maximum 181,800/mm3) and an elevated serum G-CSF to 131.7 pg/mL. After radical cystectomy and neoadjuvant chemotherapy, the tumor recurred locally. Immunohistochemical examination with monoclonal antibody specific for G-CSF revealed positive staining in the local recurrent tumor. To our knowledge, there have been only seven cases reported of bladder cancer producing G-CSF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689512     DOI: 10.1111/j.1442-2042.1996.tb00502.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  3 in total

1.  Serum G-CSF May Be a More Valuable Biomarker than Image Evaluation in G-CSF-Producing Urothelial Carcinoma: A Case Report.

Authors:  Kento Morozumi; Shunichi Namiki; Takashi Kudo; Masataka Aizawa; Naomasa Ioritani
Journal:  Case Rep Oncol       Date:  2017-04-24

Review 2.  Neutrophil Heterogeneity in Cancer: From Biology to Therapies.

Authors:  Pacôme Lecot; Matthieu Sarabi; Manuela Pereira Abrantes; Julie Mussard; Leo Koenderman; Christophe Caux; Nathalie Bendriss-Vermare; Marie-Cécile Michallet
Journal:  Front Immunol       Date:  2019-09-20       Impact factor: 7.561

3.  Problems in early diagnosis of bladder cancer in a spinal cord injury patient: report of a case of simultaneous production of granulocyte colony stimulating factor and parathyroid hormone-related protein by squamous cell carcinoma of urinary bladder.

Authors:  Subramanian Vaidyanathan; Paul Mansour; Munehisa Ueno; Kazuto Yamazaki; Meenu Wadhwa; Bakul M Soni; Gurpreet Singh; Peter L Hughes; Ian D Watson; Pradipkumar Sett
Journal:  BMC Urol       Date:  2002-08-30       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.